The importance of NF-κB as a key transcription factor in chronic inflammatory diseases, including psoriasis (Goldminz et al., 2013), has made NF-κB and its regulators an attractive target for treatment in many diseases (Gilmore and Herscovitch, 2006). This evidence concerns the gene NFKB1 and psoriasis.